Key Risk Factors for Recurrence After Rectal Cancer Surgery Insights from a Nationwide Study

Introduction
Accurate risk prediction for recurrence in rectal cancer is essential for guiding adjuvant therapy and surveillance strategies. This comprehensive study utilizes data from the Swedish ColoRectal Cancer Registry, covering patients treated between 2011 and 2018.

Key Findings
The study identified several critical risk factors influencing locoregional and distant recurrences in rectal cancer patients.

Major Risk Factors

1. Pathological Stages (pT and pN):
   • High-risk factors include pT4a (HR 5.1) and pN2b (HR 3.4), which substantially increase the risk of distant metastasis.
2. Tumor Deposits:
   • Tumor deposits emerged as a significant factor, with a HR of 1.7 for distant recurrence, highlighting the importance of thorough pathological examination.
3. Lymph Node Yield:
   • A lower lymph node yield (<12) was associated with a higher risk of recurrence (HR 1.5), underscoring the necessity for adequate lymph node dissection during surgery.
4. Tumor Level:
   • Tumors located 0-5 cm from the anal verge were associated with higher recurrence risks (HR 1.5).

Clinical Implications
These findings suggest that integrating these risk factors with traditional staging can enhance recurrence prediction and inform tailored surveillance and adjuvant treatment strategies. The role of tumor deposits and adequate lymph node assessment should be emphasized in surgical and pathological protocols.

Conclusion
This study reinforces the need for comprehensive risk stratification in rectal cancer patients to optimize post-surgical treatment and monitoring. Future research should continue to refine these risk factors and explore their implications in different treatment contexts.

Access the Original Study
For a detailed analysis, read here